Astrazeneca Latin America is categorized under Wholesale Pharmaceutical Products in Miami, FL and active since 2001.
Astrazeneca Latin America was established in 2001, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Wholesale Pharmaceutical Products business, which does work in the B2B market, and is classified as a Wholesale Pharmaceutical Products, under code number 424210 by the NAICS.
If you are seeking more information, feel free to contact Urban Skog at the company’s single location by writing to 804 South Douglas Road # 630, Miami, Florida FL 33134 or by phoning No number given. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Astrazeneca Latin America |
Contact Person: | Urban Skog |
Address: | 804 South Douglas Road # 630, Miami, Florida 33134 |
Website Address: | astrazeneca.com |
Annual Revenue (USD): | $1.000.000 to $2.499.999 |
Founded: | 2001 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2B (Business to Business) |
Business Category: | Wholesale Pharmaceutical Products |
SIC Code: | 5122 |
NAICS Code: | 424210 |
Share This Business: |
Astrazeneca Latin America was started in 2001 to provide professional Wholesale Pharmaceutical Products under the SIC code 5122 and NAICS code 424210. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.
Feel free to contact Urban Skog for inquiries that concern Astrazeneca Latin America by calling the company number No number given, as your correspondence is most welcome. Additionally, the physical location of the single location of Astrazeneca Latin America can be found at the coordinates 25.763932,-80.255256 as well as the street address 804 South Douglas Road # 630 in Miami, Florida 33134.
For its online presence, you may visit Astrazeneca Latin America’s website at astrazeneca.com and engage with its social media outlets through on Twitter and on Facebook.